乳腺癌转移性硬膜外脊髓压迫症患者接受手术联合放疗后的长期随访
该研究评估手术联合放疗对乳腺癌转移性硬膜外脊髓压迫症患者的长期疗效,随访超过10年。23例患者中,疼痛缓解率达98%,神经功能恢复率达92.9%,中位总生存期为47个月(95%CI 33-114个月)。作者认为,对于体能状态好、激素受体阳性且转移病灶局限的选定患者,应早期强烈考虑手术干预。
要点
- 23例患者接受手术联合放疗,疼痛缓解率98%,神经功能恢复率92.9%。
- 中位随访153个月,治疗部位无复发,中位总生存期47个月。
- 作者认为体能状态好、激素受体阳性、转移局限者应早期强烈考虑手术。
核心结论
- 手术联合放疗是安全可行的治疗方式,并发症发生率有限。
- 作者认为,对于体能状态好、激素受体阳性且转移病灶局限的选定患者,应早期强烈考虑手术干预。
研究设计与样本
- 研究纳入2004年至2008年间治疗的23例乳腺癌转移性硬膜外脊髓压迫症患者。
- 对体能状态好、转移病灶局限且存在进行性神经功能缺损和/或顽固性疼痛的患者行手术治疗。
- 放疗中位总剂量为30 Gy,分10次照射。
主要发现
- 最小切除占17.4%,刮除术占47.8%,全肿瘤切除占34.8%,术后78.3%的患者接受放疗。
- 疼痛缓解率达98%,神经功能恢复率达92.9%。
- 中位随访时间为153个月(范围128-209个月),治疗部位无复发。
- 中位总生存期为47个月(95%CI 33-114个月),2年、5年和10年总生存率分别为81%(±8.6%)、42.9%(±10.8%)和28.6%(±9.9%)。
- 单因素分析中,体能状态、手术切除类型、乳腺癌表型及存在其他骨转移影响生存;多因素分析证实存在其他骨转移为独立影响因素。
关键数值与推荐
- 疼痛缓解率98%,神经功能恢复率92.9%。
- 中位总生存期47个月(95%CI 33-114个月)。
- 2年、5年、10年总生存率分别为81%(±8.6%)、42.9%(±10.8%)、28.6%(±9.9%)。
临床怎么用
- 作者认为,对于体能状态好、激素受体阳性且转移病灶局限的选定患者,应早期强烈考虑手术干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate role of surgery plus radiotherapy (RT) in patients with metastatic epidural spinal cord compression from breast cancer with a follow-up >10 years. METHODS: The study included 23 patients treated between 2004 and 2008. Surgical treatment was performed in patients with good performance status, limited metastatic disease, and progressive neurologic deficit and/or intractable pain. RT was performed delivering a median total dose of 30 Gy in 10 fractions. Clinical outcome was evaluated using the modified visual analog scale for pain, Frankel grade for neurologic deficit, and magnetic resonance imaging before and after treatments and every 3 months thereafter. RESULTS: Minimal resection was performed in 17.4% of patients, curettage in 47.8%, and total tumorectomy in 34.8%, followed by RT in 78.3%. Pain remission was obtained in 98% of patients, and recovery of neurologic function was obtained in 92.9%. Median follow-up time was 153 months (range, 128-209 months). No relapse at site of treatments occurred. Median overall survival time was 47 months (95% confidence interval 33-114 months), and 2-, 5-, and 10-year overall survival rates were 81% (±8.6%), 42.9% (±10.8%), and 28.6% (±9.9%). On univariate analysis, performance status, type of surgical resection, breast cancer phenotype, and presence of other bone metastases were recorded as influencing survival; the last-mentioned was also confirmed in multivariate analysis. CONCLUSIONS: Surgery plus RT is a safe and feasible treatment with limited morbidity. In selected patients with good performance status, positive hormonal receptors, and limited metastatic disease, surgical intervention should be strongly considered early on.
引用
- Pessina F, Navarria P, Riva M, et al. Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Breast Cancer Treated with Surgery Followed by Radiotherapy. World Neurosurg. 2017. PMID: 29113903. doi:10.1016/j.wneu.2017.10.156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。